The prevalence of pulmonary hypertension assessed using the pulmonary vein‐to‐right pulmonary artery ratio and its association with survival in West Highland white terriers with canine idiopathic pulmonary fibrosis
[en] Background: Pulmonary hypertension (PH) is a known co-morbidity in West Highland white terriers (WHWTs)
affected with canine idiopathic pulmonary fibrosis (CIPF). The pulmonary vein-to-right pulmonary artery ratio (PV/
PA) has recently been described for the detection of pre-capillary PH in dogs. The objective of the present study
was to estimate the prevalence of PH at diagnostic, in WHWTs affected with CIPF, by using PV/PA, in comparison
with a group of healthy breed-matched controls (CTRLs). Additional study objective was to explo
Disciplines :
Veterinary medicine & animal health
Author, co-author :
Roels, Elodie ; Pride Veterinary Centre, DE24 8HX Derby, United Kingdom > Department of Internal Medicine
Fastrès, Aline ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Médecine interne des animaux de compagnie
Merveille, Anne-Christine ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Bolen, Géraldine ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Imagerie médicale
Teske, Erik; Faculty of Medicine, Utrecht University, 3584 CL Utrecht, The Netherlands. > Department of Clinical Sciences of Companion Animals
Clercx, Cécile ; Université de Liège - ULiège > Dép. clinique des animaux de compagnie et des équidés (DCA) > Pathologie médicale des petits animaux
Mc Entee, Kathleen; Faculty of Medicine, Université Libre de Bruxelles, 1070 Brussels, Belgium. > Laboratory of Physiology and Pharmacology
Language :
English
Title :
The prevalence of pulmonary hypertension assessed using the pulmonary vein‐to‐right pulmonary artery ratio and its association with survival in West Highland white terriers with canine idiopathic pulmonary fibrosis
Clercx C, Fastrès A, Roels E. Idiopathic pulmonary fibrosis in West Highland white terriers: An update. Vet J. 2018;242:53–8. DOI: 10.1016/j.tvjl.2018.10.007
Laurila HP, Rajamäki MM. Update on canine idiopathic pulmonary fibrosis in West Highland white terriers. Vet Clin North Am - Small Anim Pract. 2020;50:431–46. DOI: 10.1016/j.cvsm.2019.11.004
Syrjä P, Heikkilä HP, Lilja-Maula L, et al. The histopathology of idiopathic pulmonary fibrosis in West Highland white terriers shares features of both non-specific interstitial pneumonia and usual interstitial pneumonia in man. J Comp Pathol. 2013;149:303–13. DOI: 10.1016/j.jcpa.2013.03.006
Roels E, Couvreur T, Farnir F, et al. Comparison between sedation and general anesthesia for high-resolution computed tomographic characterization of canine idiopathic pulmonary fibrosis in West Highland white terriers. Vet Radiol Ultrasound. 2017;58:284–94. DOI: 10.1111/vru.12481
Thierry F, Handel I, Hammond G, et al. Further characterization of computed tomographic and clinical features for staging and prognosis of idiopathic pulmonary fibrosis in West Highland white terriers. Vet Radiol Ultrasound. 2017;58:381–8. DOI: 10.1111/vru.12491
Alfaro TM, Cordeiro CR. Comorbidity in idiopathic pulmonary fibrosis - what can biomarkers tell us ? Ther Adv Respir Dis Rev. 2020;14:1–10.
Lee J, Song J-U. The Clinical efficacy of pulmonary hypertension-specific agents in idiopathic pulmonary fibrosis: systematic review and meta-analysis of randomized controlled clinical trials. J Korean Med Sci. 2020;35:e48. DOI: 10.3346/jkms.2020.35.e48
Raghu G, Amatto VC, Behr J, Stowasser S. Comorbidities in idiopathic pulmonary fibrosis patients: a systematic literature review. Eur Respir J. 2015;46:1113–30. DOI: 10.1183/13993003.02316-2014
Torrisi SE, Vancheri A, Pavone M, et al. Pulmonary pharmacology & therapeutics comorbidities of ipf: how do they impact on prognosis. Pulm Pharmacol Ther. 2018;53:6–11. DOI: 10.1016/j.pupt.2018.09.003
Cano-Jiménez E, Gonzalez FH, Peloche GB. medical sciences Comorbidities and Complications in Idiopathic Pulmonary Fibrosis. Med Sci. 2018;6:1–13.
Currie PJ, Seward JB, Chan K, et al. Continuous wave doppler determination of right ventricular pressure: a simultaneous doppler-catheterization study in 127 patients. J Am Coll Cardiol. 1985;6:750–6. DOI: 10.1016/S0735-1097(85)80477-0
Rich J, Shah S, Swamy R, et al. Inaccuracy of Doppler echocardiophic estimated of pulmonary artery pressures in patients with pulmonary hypertension: implications for clinical practice. Chest. 2011;139:988–93. DOI: 10.1378/chest.10-1269
Soydan LC, Kellihan HB, Bates ML, et al. Accuracy of Doppler echocardiographic estimates of pulmonary artery pressures in a canine model of pulmonary hypertension. J Vet Cardiol. 2015;17:13–24. DOI: 10.1016/j.jvc.2014.10.004
Roels E, Merveille A, Malaize P, et al. Diagnostic value of pulmonary vein to pulmonary artery ratio in dogs with pulmonary hypertension of pre-capillary origin. J Vet Intern Med. 2019;31:213.
Schober KE, Baade H. Doppler echocardiographic prediction of pulmonary hypertension inWest Highland white terriers with chronic pulmonary disease. J Vet Intern Med. 2006;20:912–20. DOI: 10.1111/j.1939-1676.2006.tb01805.x
Kellihan HB, Stepien RL. Pulmonary hypertension in dogs: diagnosis and therapy. Vet Clin North Am Small Anim Pr. 2010;40:623–41. DOI: 10.1016/j.cvsm.2010.03.011
Birettoni F, Caivano D, Patata V, et al. Canine pulmonary vein-to-pulmonary artery ratio: echocardiographic technique and reference intervals. J Vet Cardiol. 2016;18:326–35. DOI: 10.1016/j.jvc.2016.07.004
Merveille AC, Bolen G, Krafft E, et al. Pulmonary vein-to-pulmonary artery ratio is an echocardiographic index of congestive heart failure in dogs with degenerative mitral valve disease. J Vet Intern Med. 2015;29:1502–9. DOI: 10.1111/jvim.13634
Lettieri C, Nathan S, Barnett S, et al. Prevalence and outcomes of pulmonary arterial hypertension in advances idiopathic pulmonary fibrosis. Chest. 2006;129:746–52. DOI: 10.1378/chest.129.3.746
Nadrous H, Pellikka P, Krowka M, et al. The impact of pulmonary hypertension on survival in patients with idiopathic pulmonary fibrosis. Chest. 2005;128:616S–7S. DOI: 10.1378/chest.128.6_suppl.616S
Jaffey JA, Wiggen K, Leach SB, et al. Pulmonary hypertension secondary to respiratory disease and/or hypoxia in dog: clinical features, diagnostic testing and survival. Vet J. 2019;251:105347. DOI: 10.1016/j.tvjl.2019.105347
Brown AJ, Davison E, Sleeper MM. Clinical efficacy of sildenafil in treatment of pulmonary arterial hypertension in dogs. J Vet Intern Med. 2010;24:850–4. DOI: 10.1111/j.1939-1676.2010.0517.x
Johnson LR, Stern JA. Clinical features and outcome in 25 dogs with respiratory- associated pulmonary hypertension treated with sildenafil. J Vet Intern Med. 2020;35:65–73. DOI: 10.1111/jvim.15679
Lilja-Maula LIO, Laurila HP, Syrjä P, et al. Long-term outcome and use of 6-minute walk test in west highland white terriers with idiopathic pulmonary fibrosis. J Vet Intern Med. 2014;28:379–85. DOI: 10.1111/jvim.12281
Heikkilä HP, Lappalainen AK, Day MJ, et al. Clinical, bronchoscopic, histopathologic, diagnostic imaging, and arterial oxygenation findings in West Highland white terriers with idiopathic pulmonary fibrosis. J Vet Intern Med. 2011;25:433–9. DOI: 10.1111/j.1939-1676.2011.0694.x
